Dallas, TX -- (SBWIRE) -- 11/01/2011 -- The global economy is heading towards a double dip phenomenon. The scenario is not very conducive for high-end capital equipments such as PET and SPECT scanners. This is delaying the purchase of new equipments and boosting the market for refurbished instruments.
Increasing awareness among the physicians with respect to nuclear imaging techniques, mounting application areas such as neurological diseases, and rising cases in oncology are driving the PET and SPECT imaging market.
Increasing aging population and widening applications of PET and SPECT imaging due to continuous developments and discovery of new radiopharmaceuticals are predominantly driving the diagnostic imaging market.
The emerging trend catching interest of the players is fusion of nuclear imaging with different modalities of diagnostic imaging products.
The merging of imaging modalities such as PET/CT, SPECT/CT, and MRI/PET helps in providing full gamut of imaging scans through the same unit and at the same time. Further, portable diagnostic equipment are facing an immense demand from physicians.
PET is more preferred as compared to SPECT imaging as PET provides higher resolution images, and the lack of availability of technetium-99m for SPECT is forcing the medical community and the industry to look for alternatives. On the other hand, the high cost of PET restricts its use in cost sensitive markets.
PET is predominately used in oncology as the quality of image provided gives more comprehensive information about the tumor. SPECT, on the other hand, holds 90% share in cardiology. PET is catching up with new radiopharmaceuticals, specifically for cardiac PET.
The U.S. accounts for the highest share of the global PET and SPECT market; followed by Europe. Asia-Pacific (excluding Japan) stands third.
The growth in the medical device industry has been spurred by Asian economies (China and India) and a few countries of South America (Brazil and Peru). Rest of the world is still lagging behind in nuclear imaging market.
Aging population and increase in the chronic disease population are considered as the main drivers of the PET and SPECT market in the developed nations and rising fiscal deficit and economic recession are expected to inhibit the growth of the developed nations.
The PET and SPECT market is highly consolidated with most of it being held by a few major players. GE Healthcare (U.K.), Philips (The Netherlands), and Siemens (Germany) together constitute above 85% of the market. GE Healthcare is a leading player due to better accompanying services along with the products. The other players trying to make an entry into the niche market are Positron Corporation (U.S), Spectrum (U.S), and Naviscan (U.S).
Scope of the report
Global PET and SPECT imaging market research report evaluates the global market of PET (Positron Emission Tomography) and SPECT (Single Photon Emission Computed Tomography) imaging with respect to the product and application market. The report analyzes geography; forecasting revenue, and trends in each of the following submarkets:
PET
PET/CT
SPECT
SPECT/CT
PET and SPECT market is also considered by the types of applications:
Oncology
Cardiology
Neurology
The geographies covered under the report are
North America
Europe
Asia-Pacific (excluding Japan)
Japan
Rest of the World
Each section provides market data, market drivers, trends and opportunities, key players, and competitive outlook. The report does provide market tables for covering the sub-segments and micro-markets. Additionally, it makes ways for company profiles that cover all the sub-segments. The report has been made by keeping past trends, current happenings and future forecasts in minds.
Releated Report : Medical Devices Market
http://www.marketsandmarkets.com/medical-device-market-research-11.html
PET (Positron Emission Tomography) and SPECT (Single Photon Emission Computed Tomography) Global Market (Technology and Applications) (2011-2016) http://www.marketsandmarkets.com/Market-Reports/pet-market-98.html
About MarketsandMarkets
MarketsandMarkets (M&M) is a global market research and consulting company based in the U.S. We publish strategic advisory reports and serve as a business intelligence partner to Fortune 500 companies across the globe. MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services.
M&M Banking and Financial Services Practice recognize the challenges that financial institutions face while bringing the right products to market. Our reports and consulting practice provides a unique perspective allowing financial institutions to understand and strategize to achieve their product goals. Through a mix of case studies, primary research, and business modeling we provide a 360° view to identify how our clients can create, capture, and retain the value of their products and outthink the competition.
http://twitter.com/marketsmarkets